News & Analysis on Clinical Trial Services & Contract Research And Development
Swiss contract manufacturing company Lonza has licensed a technology that makes it possible to make peptide drugs that are longer and have a more complex structure than is possible using conventional techniques, reports Phil Taylor.
Signalling its continued commitment to the emerging economies of the recently expanded European Union, Switzerland's Novartis has unveiled a €70 million overall investment in a new generics production and logistics facility in Strykow, Poland.
The European Commission has mapped out its strategy to keep the European Union at the forefront of research into nanotechnology, a position that is in danger of being eroded, and plans to double its funding in the sector writes Phil Taylor.
UK chemicals and metals firm Johnson Matthey has opened a precious metal process catalyst manufacturing plant in India to cater to the growing demand from the local pharmaceutical industry and provide a springboard into other Asian markets.